JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
56 * ! | Sun, 7/31/2011, 4:00 PM - 5:50 PM | CC-D240 | |
Reimbursement, Market Access, Health Technology Assessments, and Their Roles in the 4th Hurdle — Invited Papers | |||
Leadership Support Council | |||
Organizer(s): Grace Song-ye Park, Amgen Inc. | |||
Chair(s): Christine Anne Fletcher, Amgen Inc. | |||
4:05 PM | Proposed National Standards for Reviews of Health Care Evidence — Christopher Schmid, Tufts Medical Center | ||
4:30 PM | Optimizing Clinical Trial Design to Maximize Market Access Success — Christine Anne Fletcher, Amgen Inc. ; Grace Song-ye Park, Amgen Inc. | ||
4:55 PM | Challenges in the FDA Statistical Reviews of Submissions Containing Patient-Reported Outcomes (PROs) — Lisa A. Kammerman, U.S. Food and Drug Administration | ||
5:20 PM | Discussant: Rhys Williams, Amgen Inc. | ||
5:45 PM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.